AmCad BioMed Corporation (TPEX:4188)
Taiwan
· Delayed Price · Currency is TWD 12.90
-0.05 (-0.39%)
Mar 10, 2026, 11:32 AM CST
AmCad BioMed Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -55.72 | -50.58 | -45.31 | -53.49 | -25.54 | Upgrade
|
| Depreciation & Amortization | 15.8 | 18 | 17.16 | 17.27 | 17.9 | Upgrade
|
| Other Amortization | - | 0.28 | 0.3 | 0.35 | 0.38 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.22 | 0.19 | 0.17 | 0.01 | 0.08 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.46 | -0.03 | -0 | -0.02 | -0 | Upgrade
|
| Stock-Based Compensation | 0.64 | 2.9 | 0.68 | 0.82 | 0.54 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | -0.05 | -0.1 | Upgrade
|
| Other Operating Activities | -15.71 | -2.31 | 2.16 | -0.86 | -1.35 | Upgrade
|
| Change in Accounts Receivable | 11.31 | -9.31 | -6.84 | 1.33 | -2.93 | Upgrade
|
| Change in Inventory | 0.48 | -11.61 | -5.41 | -2.6 | 0.02 | Upgrade
|
| Change in Accounts Payable | -1.42 | 0.9 | 0.96 | -0.21 | -0.04 | Upgrade
|
| Change in Unearned Revenue | -0.06 | -1.54 | -0.61 | -2.78 | -31.61 | Upgrade
|
| Change in Other Net Operating Assets | -2.15 | 1.25 | -4.86 | 6.03 | 3.68 | Upgrade
|
| Operating Cash Flow | -47.06 | -51.85 | -41.6 | -34.19 | -38.97 | Upgrade
|
| Capital Expenditures | -0.37 | -2.72 | -0.29 | -0.61 | -2.34 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.33 | -0.33 | - | - | - | Upgrade
|
| Investment in Securities | 59.51 | -182.81 | 26.19 | 28.76 | 51.18 | Upgrade
|
| Other Investing Activities | 0.12 | 0.43 | 1.42 | -1.01 | 0.33 | Upgrade
|
| Investing Cash Flow | 58.93 | -185.43 | 27.31 | 27.14 | 49.18 | Upgrade
|
| Long-Term Debt Repaid | -5.05 | -5.25 | -4.42 | -4.42 | -4.54 | Upgrade
|
| Net Debt Issued (Repaid) | -5.05 | -5.25 | -4.42 | -4.42 | -4.54 | Upgrade
|
| Issuance of Common Stock | - | 230.63 | 1.32 | - | - | Upgrade
|
| Other Financing Activities | 0.03 | - | - | 0.01 | -6.8 | Upgrade
|
| Financing Cash Flow | -5.02 | 225.38 | -3.1 | -4.42 | -11.35 | Upgrade
|
| Net Cash Flow | 6.85 | -11.9 | -17.39 | -11.47 | -1.13 | Upgrade
|
| Free Cash Flow | -47.44 | -54.57 | -41.89 | -34.81 | -41.3 | Upgrade
|
| Free Cash Flow Margin | -155.85% | -102.76% | -64.20% | -56.48% | -48.14% | Upgrade
|
| Free Cash Flow Per Share | -0.75 | -0.95 | -0.79 | -0.65 | -0.78 | Upgrade
|
| Cash Interest Paid | 0.09 | 0.18 | 0.12 | 0.12 | 0.14 | Upgrade
|
| Cash Income Tax Paid | - | 0.01 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -28.86 | -36.17 | -29.01 | -20.2 | -33.04 | Upgrade
|
| Unlevered Free Cash Flow | -28.81 | -36.06 | -28.94 | -20.13 | -32.95 | Upgrade
|
| Change in Working Capital | 8.17 | -20.31 | -16.76 | 1.76 | -30.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.